Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03888014 · ClinicalTrials.gov registry record
Intraoperative Fluorescence With Augmented Reality
A clinical trial, sponsored by Cedars-Sinai Medical Center.
- Completed
- Registry status
- 7
- Enrollment target
NCT03888014 is a clinical trial that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 7 participants.
The verdict
NCT03888014 has completed, sponsored by Cedars-Sinai Medical Center.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
Study Summary
This is a study looking at a new way to evaluate vascular problems or tumors in brain surgery patients using a standard \& approved intravenous dye and augmented reality.
Interventions
- DRUG indocyanine green (ICG)
- DEVICE GLOW800
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2019-07-01 |
| Est. Completion | 2021-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03888014
The ClinicalTrials.gov registry entry for NCT03888014 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which indocyanine green (ICG) is the first listed.
NCT03888014 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03888014 about?
NCT03888014 is a clinical study titled "Intraoperative Fluorescence With Augmented Reality". This is a study looking at a new way to evaluate vascular problems or tumors in brain surgery patients using a standard \& approved intravenous dye and augmented reality.
What is the current status of trial NCT03888014?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2019-07-01. Estimated completion is 2021-06-01.
What interventions are being tested in trial NCT03888014?
The interventions under investigation include: indocyanine green (ICG) (DRUG), GLOW800 (DEVICE).
Who is sponsoring clinical trial NCT03888014?
This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.